3 Dividend Stocks to Hold for the Long Haul
Key takeaways
- NVDA ^GSPC BMY MDT MRK Investing in dividend stocks is a great way to earn superior returns over the long run.
- In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia.
- Bristol Myers is a leading pharmaceutical company with a deep portfolio of medicines spanning many therapeutic areas, particularly oncology.
NVDA ^GSPC BMY MDT MRK Investing in dividend stocks is a great way to earn superior returns over the long run. How do we know that? According to some research, most of the S&P 500 s returns over the past several decades can be attributed to reinvested dividends and compounding. This fact makes a strong case for dividend investing. However, buying shares in just any old company that happens to pay dividends isn t the way to go: They aren t all created equal. With that said, let s consider three excellent dividend stocks that are worth investors hard-earned cash: Bristol Myers Squibb (NYSE: BMY), Merck (NYSE: MRK), and Medtronic (NYSE: MDT). Here s why these three income stocks are worth sticking with for the long term.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Bristol Myers is a leading pharmaceutical company with a deep portfolio of medicines spanning many therapeutic areas, particularly oncology. The drugmaker typically generates decent revenue and earnings, although it has encountered challenges in recent years due to patent cliffs. Bristol Myers is bouncing back, though. Newer approvals are helping push sales in the right direction. The company s first-quarter revenue climbed by 3% year over year to $11.5 billion.